News
Market and company headlines
NEOGAll
Loading
11:00Oct 201 Story
11:00Oct 191 Story
11:00Oct 131 Story
07:00Oct 121 Story
15:00Oct 101 Story
07:00-13:00Oct 82 Stories
Neogen (NEOG) Received An FDA Warning Over Contaminated Veterinary Product
Neogen (NasdaqGS:NEOG) received a formal FDA warning letter tied to contamination issues in its HYCOAT(R) veterinary product. Regulators cited significant manufacturing violations at HYCOAT(R) production facilities that they linked to serious adverse events in horses. The FDA findings referenced multiple horse deaths following HYCOAT(R) use and triggered a recall of affected product lots. The HYCOAT(R) contamination and FDA warning letter give important context, but investors need a wider...
Why Is Neogen Stock Gaining Thursday?
Neogen (NEOG) stock rises after outlining ambitious FY31 targets at Investor Day, including 30% EBITDA margins & R&D expansion.
03:00-07:00Oct 82 Stories
Neogen Corporation: Promising Recurring Demand With Food Safety
Neogen Corporation's products are used for detecting contamination, checking quality, and protecting livestock. Read more on NEOG stock here.
The 5 Most Interesting Analyst Questions From Neogen’s Q3 Earnings Call
Neogen’s third quarter results showed progress in both its Food and Animal Safety segments, but the market reaction was negative. Management attributed the quarter’s performance to improved commercial execution, targeted customer engagement, and operational discipline. CEO Mikhael Nassif highlighted “tangible signs that the changes underway across Neogen are taking hold,” particularly with strengthened inventory planning and cross-functional collaboration. However, the company acknowledged that
22:00Oct 72 Stories
Neogen Corporation (NEOG) Analyst/Investor Day - Slideshow
2026-10-08. The following slide deck was published by Neogen Corporation in conjunction with this event.
Neogen Investor Day Sets Path for Growth, 30% EBITDA Margin by 2031
Neogen (NASDAQ:NEOG) outlined a multi-year strategy at its first Investor Day, emphasizing a shift from business stabilization toward accelerated growth, higher margins and stronger cash generation. Management said the company has delivered positive core growth for four consecutive quarters and is t
14:00-19:00Oct 72 Stories
Neogen Outlines Strategy for Growth, Innovation and Margin Expansion at 2026 Investor Day
LANSING, Mich., October 07, 2026--Neogen Corporation (NASDAQ: NEOG) today hosted its 2026 Investor Day, "Shaping the Future of Food Safety," in New York City, where the company's senior leadership team outlined a comprehensive strategy for sustained profitable growth and category leadership, and provided a framework under which it plans to achieve financial targets by fiscal year 2031.
Why Are Neogen (NEOG) Shares Soaring Today
Shares of life sciences company Neogen (NASDAQ:NEOG) jumped 14.1% in the pre-market session after the company reported its third-quarter 2026 financial results and raised its full-year guidance for revenue and adjusted EBITDA.
11:00-14:00Oct 72 Stories
Neogen Corporation (NEOG) Analyst/Investor Day Transcript
Neogen Corporation (NEOG) Analyst/Investor Day October 7, 2026 9:00 AM EDTCompany ParticipantsBill WaelkeMikhael Nassif - CEO, President &...
Neogen (NEOG) Q1 2027 Earnings Call Transcript
Revenue grew 6.5% as Food Safety and Animal Safety segments both expanded.
09:00Oct 71 Story
17:00-20:00Oct 62 Stories
What Neogen (NEOG) Said on Its Q1 Earnings Call
Neogen (NASDAQ:NEOG) reported fiscal 2027 first-quarter revenue of $222.8 million, with core growth of 8.1%, as the company cited improved commercial execution, product-line strength in food safety and animal safety, and progress on its Petrifilm manufacturing transition. Chief Executive Officer Mi
Compared to Estimates, Neogen (NEOG) Q1 Earnings: A Look at Key Metrics
Although the revenue and EPS for Neogen (NEOG) give a sense of how its business performed in the quarter ended August 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
16:00Oct 66 Stories
Neogen’s (NASDAQ:NEOG) Q3 CY2026: Strong Sales, Stock Soars
Life sciences company Neogen (NASDAQ:NEOG) reported calendar Q3 2026 (fiscal Q1 2027) results exceeding the market’s revenue expectations, with sales up 6.5% year on year to $222.8 million. The company expects the full year’s revenue to be around $887.5 million, close to analysts’ estimates. Its non-GAAP profit of $0.08 per share was 50% above analysts’ consensus estimates.
Neogen (NASDAQ:NEOG) Shares Jump After Q1 Beat and Raised Fiscal 2027 Guidance
Neogen beats Q1 estimates, raises FY27 outlook, shares jump 9% as margin reset gains traction.
23:00Oct 41 Story
03:00Oct 21 Story
07:00-09:00Oct 12 Stories
Unlocking Q1 Potential of Neogen (NEOG): Exploring Wall Street Estimates for Key Metrics
Evaluate the expected performance of Neogen (NEOG) for the quarter ended August 2026, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Neogen Stock Rallies 83% YTD: What's Driving the Surge?
NEOG's 83% YTD rally reflects Food Safety momentum, Petrifilm expansion, solutions-based selling and a growing product pipeline.
04:00-11:00Sep 302 Stories
10:00-20:00Sep 292 Stories
Neogen (NEOG) Stock Trades Down, Here Is Why
Shares of life sciences company Neogen (NASDAQ:NEOG) fell 5.4% in the afternoon session after the U.S. Food and Drug Administration issued warning letters to the company following laboratory tests that uncovered fungal contamination in its veterinary product HYCOAT.
Why is Neogen Stock Trading Lower on Tuesday?
FDA warns Neogen Vet after fungal contamination in HYCOAT solution caused unprecedented horse deaths and severe manufacturing defects.
